QBIO (Q BioMed) Total Liabilities: $9.91 Mil (As of Feb. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Q BioMed Total Liabilities?

Q BioMed QBIO -99.00% Total Liabilities is $9.91 Mil as of Feb. 2023.

Q BioMed's Total Liabilities for the quarter that ended in Feb. 2023 was $9.91 Mil.

Q BioMed's quarterly Total Liabilities increased from Aug. 2022 ($7.73 Mil) to Nov. 2022 ($8.13 Mil) and increased from Nov. 2022 ($8.13 Mil) to Feb. 2023 ($9.91 Mil).

Q BioMed's annual Total Liabilities increased from Nov. 2020 ($1.70 Mil) to Nov. 2021 ($5.50 Mil) and increased from Nov. 2021 ($5.50 Mil) to Nov. 2022 ($8.13 Mil).

Q BioMed Total Liabilities Historical Data

* Premium members only.

The historical data trend for Q BioMed's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q BioMed Total Liabilities Chart

Q BioMed Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.30 5.69 1.70 5.50 8.13

Q BioMed Quarterly Data
May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.37 7.56 7.73 8.13 9.91

Q BioMed Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Q BioMed's Total Liabilities for the fiscal year that ended in Nov. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.133+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=8.13

Total Liabilities=Total Assets (A: Nov. 2022 )-Total Equity (A: Nov. 2022 )
=3.516--4.617
=8.13

Q BioMed's Total Liabilities for the quarter that ended in Feb. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9.906+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=9.91

Total Liabilities=Total Assets (Q: Feb. 2023 )-Total Equity (Q: Feb. 2023 )
=3.465--6.441
=9.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $9.91 Mil mean?
Q BioMed (QBIO) has a Total Liabilities of $9.91 Mil as of Feb. 2023. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Q BioMed and its competitors.
Is Q BioMed's Total Liabilities too high?
Q BioMed's current Total Liabilities is $9.91 Mil.
How does Q BioMed's Total Liabilities compare to RGMP and CALA?
Q BioMed's Total Liabilities of $9.91 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Q BioMed and its competitors. Q BioMed's current Total Liabilities is $9.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q BioMed stock overvalued right now?
Q BioMed (QBIO) has a current Total Liabilities of $9.91 Mil. The current Total Liabilities is $9.91 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Q BioMed (QBIO), the current Total Liabilities is $9.91 Mil as of Feb. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q BioMed Business Description

Address c/o Ortoli Rosenstadt LLP, 366 Madison Avenue, 3rd Floor, New York, NY, USA, 10017
Q BioMed Inc is a biotech acceleration and commercial stage company. It is focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. The company provides these target assets the strategic resources, developmental support, and expansion capital needed to ensure customers meet their developmental potential, enabling them to provide products to patients in need.